Lilly exclusive worldwide rights to RRMS and SPMS compound, MBP8298
Lilly to Acquire Exclusive Rights to Novel Late-Stage Molecule for the Treatment of Multiple ... more »
|
|||
|
Multiple Sclerosis Info
If you want this blog to continue, than make it financialy viable for Bonnie to continue it. She puts in 2-3 hours a day into this blog, and spends money on it for it's upkeep.
Search
This Month
|
Sunday, December 30
Lilly has exclusive rights to RRMS and SPMS compound, MBP8298
by
All About MS
on Sun 30 Dec 2007 08:44 PM CST
Initiation Of Enrollment In Pivotal Phase III Clinical Study Of Oral Laquinimod For RRMS
by
All About MS
on Sun 30 Dec 2007 09:18 AM CST
Initiation Of Enrollment In Pivotal Phase III Clinical Study Of Oral Laquinimod For Relapsing-Remitting Multiple Sclerosis
Teva Pharmaceutical Industries Ltd. ... more » |
||